Parallax Volatility Advisers »

Cytokinetics shares owned by Parallax Volatility Advisers

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Parallax Volatility Advisers from 13F filings

Historical chart of Parallax Volatility Advisers investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Parallax Volatility Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Parallax Volatility Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 18k 83.49
2022-12-31 $2.6M 57k 45.82
2022-09-30 $3.1M 62k 49.63
2021-03-31 $865k 39k 21.98
2020-09-30 $240k 11k 21.54
2017-12-31 $52k 6.3k 8.20

More positions owned by Parallax Volatility Advisers

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Call Option (META)
NVIDIA Corporation (NVDA)
Tesla Motors Call Option (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Gold Tr Gold Shs Put Option (GLD)
Select Sector Spdr Tr Energy (XLE)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Palo Alto Networks (PANW)
Amazon (AMZN)
Royal Caribbean Cruises Put Option (RCL)

View all positions for Parallax Volatility Advisers

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics